Ivan J Keogh1, Maria J Troulis, Angelo A Monroy, Roland D Eavey, L B Kaban. 1. Department of Otolaryngology, Pediatric Otolaryngology Service, Massachusetts Eye and Ear Infirmary, and Department of Genetics, Harvard Medical School, Boston, MA, USA. ivankeogh@oceanfree.net
Abstract
OBJECTIVE: To determine the proportion of hemifacial microsomia (HFM) in patients with unilateral or bilateral "isolated" microtia. DESIGN: Prospective cohort clinical study. SETTING: University-affiliated, tertiary referral clinic for patients with microtia. PATIENTS: One hundred consecutive patients with isolated microtia. INTERVENTIONS: All the patients underwent a clinical examination and audiologic evaluation. The OMENS classification system was used to grade the severity of craniofacial features: orbital deformity, mandibular hypoplasia, ear deformity, nerve (cranial nerve VII) involvement, and soft-tissue deficiency. Each anatomical abnormality was graded from 0 (normal) to 3 (most severe) (score range, 0-15). MAIN OUTCOME MEASURES: The OMENS scores, percentage of patients with isolated microtia and undiagnosed HFM, and isolated microtia as an early clinical marker for HFM. RESULTS: Forty patients (40%) with microtia were determined to have HFM (31 unilateral and 9 bilateral). Mean patient age was 9.2 years (range, 6 weeks to 41 years), with male predominance (27 males and 13 females). The OMENS scores were less than 5 in 24 patients and 6 to 10 in 16 patients. Thirty patients had cranial nerve deficits, and 37 had mandibular asymmetry. Thirty-seven patients demonstrated conductive hearing loss, and 1 had sensorineural hearing loss. CONCLUSIONS: Isolated microtia served as an early clinical marker for asymmetrical facial growth in 40% of the patients. Isolated microtia and HFM could represent a spectrum of expression of the same developmental phenomenon.
OBJECTIVE: To determine the proportion of hemifacial microsomia (HFM) in patients with unilateral or bilateral "isolated" microtia. DESIGN: Prospective cohort clinical study. SETTING: University-affiliated, tertiary referral clinic for patients with microtia. PATIENTS: One hundred consecutive patients with isolated microtia. INTERVENTIONS: All the patients underwent a clinical examination and audiologic evaluation. The OMENS classification system was used to grade the severity of craniofacial features: orbital deformity, mandibular hypoplasia, ear deformity, nerve (cranial nerve VII) involvement, and soft-tissue deficiency. Each anatomical abnormality was graded from 0 (normal) to 3 (most severe) (score range, 0-15). MAIN OUTCOME MEASURES: The OMENS scores, percentage of patients with isolated microtia and undiagnosed HFM, and isolated microtia as an early clinical marker for HFM. RESULTS: Forty patients (40%) with microtia were determined to have HFM (31 unilateral and 9 bilateral). Mean patient age was 9.2 years (range, 6 weeks to 41 years), with male predominance (27 males and 13 females). The OMENS scores were less than 5 in 24 patients and 6 to 10 in 16 patients. Thirty patients had cranial nerve deficits, and 37 had mandibular asymmetry. Thirty-seven patients demonstrated conductive hearing loss, and 1 had sensorineural hearing loss. CONCLUSIONS:Isolated microtia served as an early clinical marker for asymmetrical facial growth in 40% of the patients. Isolated microtia and HFM could represent a spectrum of expression of the same developmental phenomenon.
Authors: Daniela V Luquetti; Matthew L Speltz; Erin R Wallace; Babette Siebold; Brent R Collett; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Sara L Kinter; Brian G Leroux; Leanne Magee; Susan Norton; Kathleen Sie; Carrie L Heike Journal: Cleft Palate Craniofac J Date: 2019-01-08
Authors: Babette Siebold; Carrie L Heike; Brian G Leroux; Matthew L Speltz; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Leanne Magee; Daniela V Luquetti Journal: Birth Defects Res Date: 2019-03-30 Impact factor: 2.344
Authors: Matthew L Speltz; Kathleen A Kapp-Simon; Alexis L Johns; Erin R Wallace; Brent R Collett; Leanne Magee; Brian G Leroux; Daniela V Luquetti; Carrie L Heike Journal: J Pediatr Date: 2018-04-22 Impact factor: 4.406
Authors: J Mortier; J van den Ende; F Declau; H Vercruysse; W Wuyts; G Van Camp; O Vanderveken; An Boudewyns Journal: Eur Arch Otorhinolaryngol Date: 2022-06-27 Impact factor: 2.503
Authors: Daniel Quiat; Seong Won Kim; Qi Zhang; Sarah U Morton; Alexandre C Pereira; Steven R DePalma; Jon A L Willcox; Barbara McDonough; Daniel M DeLaughter; Joshua M Gorham; Justin J Curran; Melissa Tumblin; Yamileth Nicolau; Maria A Artunduaga; Lourdes Quintanilla-Dieck; Gabriel Osorno; Luis Serrano; Usama Hamdan; Roland D Eavey; Christine E Seidman; J G Seidman Journal: Proc Natl Acad Sci U S A Date: 2022-05-18 Impact factor: 12.779
Authors: Daniela V Luquetti; Carrie L Heike; Ignacio Zarante; Andrew E Timms; Jonas Gustafson; Harry Pachajoa; Gloria L Porras-Hurtado; Paola Ayala-Ramirez; Milagros M Duenas-Roque; Natalia Jimenez; Lina M Ibanez; Paula Hurtado-Villa Journal: Mol Genet Genomic Med Date: 2020-09-01 Impact factor: 2.183